Phase 3Withdrawn
Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin
Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome (PCOS) and a Resistance to Insulin. Randomised Controlled Study
- Sponsor
- Clinique Ovo (Industry)
- Conditions
- Polycystic Ovary Syndrome; Insulin Resistance
- Interventions
- Metformin; Clomiphene citrate
- Ages
- adults
- Registry
- NCT01638988
Full record on ClinicalTrials.gov
From the registry
The results of studies conducted until now does not determine what the best way to treat infertility in the first line with patients with Polycystic ovary syndrome (PCOS). This study objective is to determine the best treatment for such patients. The long-term consequence health of women with PCOS are multiple. The woman with PCOS has a risk of developing metabolic diseases, heart diseases, diabetes Type II or anovulatory infertility. The insulin resistance plays an important role in all this medical condition. Clomiphene Citrate (CC) remains the first line treatment to induce ovulation in women with PCOS and anovulatory infertility.
Primary outcomes
- Biochemical pregnancy
History
Study completion
Last registry update
Primary completion
Started
Registered